FDA Issues Final Guidance on Assessing User Fees Under GDUFA II

The FDA formalized user fee assessment changes under the Generic Drug User Fee Act of 2017 (GDUFA) in a final guidance released yesterday, adding a new section on refunds to sponsors.
Source: Drug Industry Daily